Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01714583 · ClinicalTrials.gov registry record
The Relationship Between Positive End Expiratory Pressure and Cardiac Index in Patients With Acute Respiratory Distress Syndrome (ARDS) Managed on a Fluid Protocol
A clinical trial of Acute Respiratory Distress Syndrome (ARDS), sponsored by Yale University.
- Completed
- Registry status
- 367
- Enrollment target
- 1
- Study location
NCT01714583: Completed study of Acute Respiratory Distress Syndrome (ARDS), sponsored by Yale University.
NCT01714583 is a study of Acute Respiratory Distress Syndrome (ARDS) that has completed, run by Yale University. The registered enrollment target is 367 participants, below the 17,689-participant average among 8 other Acute Respiratory Distress Syndrome (ARDS) trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01714583, a study of Acute Respiratory Distress Syndrome (ARDS), has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- 367 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to evaluate the association between positive end-expiratory pressure (PEEP) setting and cardiac function, as measured by cardiac index, in patients with acute respiratory distress syndrome (ARDS) who were managed on the NHLBI ARDS Network Fluid and Catheter Treatment Trial (FACTT) fluid protocols.
Primary Outcome
The cardiac index is a cardiodynamic measure based on the cardiac output, which is the amount of blood the left ventricle ejects into the systemic circulation in one minute, measured in liters per minute (l/min). Cardiac output is indexed to a patient's body size by dividing by the body surface area to yield the cardiac index. The cardiac index which is the outcome measure is assessed at the same time as the PEEP (which is the independent variable) is measured. The study participants are NOT f
Conditions Studied
Study Locations (1)
Connecticut
- Yale University, School of Medicine, Department of Internal Medicine, Section of Pulmonary and Critical Care Medicine - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 367 participants |
| Start Date | 2011-04 |
| Est. Completion | 2012-09 |
What the finished NCT01714583 record still lists
NCT01714583 is an observational study that tracks outcomes without assigning an intervention. The registered 367 participants enrollment target is mid-sized for trials with a published cap, below the 17,689-participant average among 8 other Acute Respiratory Distress Syndrome (ARDS) trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Acute Respiratory Distress Syndrome (ARDS) appearing as the primary indexed condition, and to 0 interventions.
NCT01714583 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT01714583 about?
NCT01714583 is a clinical study titled "The Relationship Between Positive End Expiratory Pressure and Cardiac Index in Patients With Acute Respiratory Distress Syndrome (ARDS) Managed on a Fluid Protocol". The objective of this study is to evaluate the association between positive end-expiratory pressure (PEEP) setting and cardiac function, as measured by cardiac index, in patients with acute respiratory distress syndrome (ARDS) who were managed on the NHLBI ARDS Network Fluid and Catheter Treatment T...
What is the current status of trial NCT01714583?
This trial is currently completed. The enrollment target is 367 participants. The study started on 2011-04. Estimated completion is 2012-09.
What conditions does trial NCT01714583 study?
This clinical trial studies the following conditions: Acute Respiratory Distress Syndrome (ARDS).
Who is sponsoring clinical trial NCT01714583?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01714583 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Respiratory Distress Syndrome (ARDS)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01714583's enrollment target sits among peer trials
367 3rd of 8 higher than 6 of 8 other Acute Respiratory Distress Syndrome (ARDS) trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Acute Respiratory Distress Syndrome (ARDS) trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS (Master Record)
RECRUITING · Phase 2
-
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort C: Bevacizumab
RECRUITING · Phase 2
-
Pediatric Acute Respiratory Distress Syndrome (ARDS) Management Trial
RECRUITING · Phase 2
-
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort A: Vilobelimab
RECRUITING · Phase 2
-
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort B: Paridiprubart
RECRUITING · Phase 2
-
An Observational Study to Identify New Health Problems Arising After an Intensive Care Unit Admission in People With Acute Respiratory Distress Syndrome in the United States
ACTIVE NOT RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04675476 · 368 participants · NA
A Patient and Provider Intervention to Address Health Disparities in Lung Cancer Screening
- NCT05215353 · 368 participants · Phase 4
A Study Comparing Music Therapy and Cognitive Behavioral Therapy for Anxiety in Cancer Survivors
- NCT06182397 · 368 participants · NA
Sirolimus Coated BALloon Versus Standard Balloon Angioplasty in The Treatment of Below The Knee Arterial Disease
- NCT06629610 · 368 participants · NA
Diet and Active Lifestyle - Yuuyaraq (The Yup'ik Way of Life)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia